BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

318 related articles for article (PubMed ID: 8073949)

  • 1. The mechanism of V(D)J joining: lessons from molecular, immunological, and comparative analyses.
    Lewis SM
    Adv Immunol; 1994; 56():27-150. PubMed ID: 8073949
    [No Abstract]   [Full Text] [Related]  

  • 2. The mechanism of V(D)J recombination: a balance of diversity, specificity, and stability.
    Lieber MR
    Cell; 1992 Sep; 70(6):873-6. PubMed ID: 1525825
    [No Abstract]   [Full Text] [Related]  

  • 3. New insights into V(D)J recombination and its role in the evolution of the immune system.
    Thompson CB
    Immunity; 1995 Nov; 3(5):531-9. PubMed ID: 7584143
    [No Abstract]   [Full Text] [Related]  

  • 4. Cutting apart V(D)J recombination.
    Oettinger MA
    Curr Opin Genet Dev; 1996 Apr; 6(2):141-5. PubMed ID: 8722168
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Signal joint formation is inhibited in murine scid preB cells and fibroblasts in substrates with homopolymeric coding ends.
    Sun T; Ezekiel UR; Erskine L; Agulo R; Bozek G; Roth D; Storb U
    Mol Immunol; 1999 Jun; 36(8):551-8. PubMed ID: 10475610
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Influence of the V(D)J recombination mechanism on the formation of the primary T and B cell repertoires.
    Feeney AJ; Victor KD; Vu K; Nadel B; Chukwuocha RU
    Semin Immunol; 1994 Jun; 6(3):155-63. PubMed ID: 7948955
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cell type-specific chromatin structure determines the targeting of V(D)J recombinase activity in vitro.
    Stanhope-Baker P; Hudson KM; Shaffer AL; Constantinescu A; Schlissel MS
    Cell; 1996 Jun; 85(6):887-97. PubMed ID: 8681383
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mechanisms that control antigen receptor variable region gene assembly.
    Okada A; Alt FW
    Semin Immunol; 1994 Jun; 6(3):185-96. PubMed ID: 7948958
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Recent advances in understanding V(D)J recombination.
    Gellert M
    Adv Immunol; 1997; 64():39-64. PubMed ID: 9100979
    [No Abstract]   [Full Text] [Related]  

  • 10. Coding sequence composition flanking either signal element alters V(D)J recombination efficiency.
    Boubnov NV; Wills ZP; Weaver DT
    Nucleic Acids Res; 1995 Mar; 23(6):1060-7. PubMed ID: 7731794
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Targeted disruption of the Artemis murine counterpart results in SCID and defective V(D)J recombination that is partially corrected with bone marrow transplantation.
    Li L; Salido E; Zhou Y; Bhattacharyya S; Yannone SM; Dunn E; Meneses J; Feeney AJ; Cowan MJ
    J Immunol; 2005 Feb; 174(4):2420-8. PubMed ID: 15699179
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A biochemically defined system for coding joint formation in V(D)J recombination.
    Lu H; Shimazaki N; Raval P; Gu J; Watanabe G; Schwarz K; Swanson PC; Lieber MR
    Mol Cell; 2008 Aug; 31(4):485-497. PubMed ID: 18722175
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Allelic exclusion in B and T lymphopoiesis.
    Bergman Y
    Semin Immunol; 1999 Oct; 11(5):319-28. PubMed ID: 10497086
    [TBL] [Abstract][Full Text] [Related]  

  • 14. RAG-1 and RAG-2, adjacent genes that synergistically activate V(D)J recombination.
    Oettinger MA; Schatz DG; Gorka C; Baltimore D
    Science; 1990 Jun; 248(4962):1517-23. PubMed ID: 2360047
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Excised V(D)J recombination byproducts threaten genomic integrity.
    Arnal SM; Roth DB
    Trends Immunol; 2007 Jul; 28(7):289-92. PubMed ID: 17544847
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Coding joint formation in a cell-free V(D)J recombination system.
    Leu TM; Eastman QM; Schatz DG
    Immunity; 1997 Aug; 7(2):303-14. PubMed ID: 9285414
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Reassignment of the murine 3'TRDD1 recombination signal sequence.
    Touvrey C; Cowell LG; Lieberman AE; Marche PN; Jouvin-Marche E; Candéias SM
    Immunogenetics; 2006 Nov; 58(11):895-903. PubMed ID: 17021860
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Restraining the V(D)J recombinase.
    Roth DB
    Nat Rev Immunol; 2003 Aug; 3(8):656-66. PubMed ID: 12974480
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Genomic instability due to V(D)J recombination-associated transposition.
    Reddy YV; Perkins EJ; Ramsden DA
    Genes Dev; 2006 Jun; 20(12):1575-82. PubMed ID: 16778076
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Complementation of V(D)J recombination defect and X-ray sensitivity of scid mouse cells by human chromosome 8.
    Banga SS; Hall KT; Sandhu AK; Weaver DT; Athwal RS
    Mutat Res; 1994 Nov; 315(3):239-47. PubMed ID: 7526201
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.